On November 21, 2024, Canada's University Health Network announced that Toronto Western Hospital will be the first non-US site to conduct a clinical trial for a device developed by Neuralink Corp., the brain-implant company founded by Elon Musk.
UHN Chief Executive Officer Kevin Smith expressed pride in leading this advancement in neurosurgery, confirming that the hospital would serve as the 'first and exclusive' trial site in Canada. Specific details regarding the trial's commencement date have not yet been disclosed.